Cargando…

Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis

Objectives. To evaluate the multi-biomarker disease activity (MBDA) score as a predictor of radiographic progression and compare it with other risk factors among patients with established RA receiving non-biologic DMARDs. Methods. For 163 patients with RA, we assessed 271 visits for MBDA score (scal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wanying, Sasso, Eric H., van der Helm-van Mil, Annette H. M., Huizinga, Tom W. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710803/ https://www.ncbi.nlm.nih.gov/pubmed/26385370 http://dx.doi.org/10.1093/rheumatology/kev341

Ejemplares similares

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
por: van der Helm-van Mil, Annette H. M., et al.
Publicado: (2013)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis
por: Mangnus, Lukas, et al.
Publicado: (2015)

Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons
por: Mangnus, Lukas, et al.
Publicado: (2016)

Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study
por: van Steenbergen, Hanna W, et al.
Publicado: (2015)

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2005)

Does the multi-biomarker disease activity score have diagnostic value in early rheumatoid arthritis and unclassified arthritis?
por: Maijer, Karen I, et al.
Publicado: (2015)

Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006)

Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody–negative arthralgia patients at risk for rheumatoid arthritis
por: van Steenbergen, Hanna W, et al.
Publicado: (2014)

Earlier chronotype in patients with rheumatoid arthritis
por: Habers, G. Esther A., et al.
Publicado: (2021)

Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands
por: Matthijssen, Xanthe M. E., et al.
Publicado: (2020)

Validity of the rheumatoid arthritis MRI score applied to the forefeet using the OMERACT filter: a systematic literature review
por: Dakkak, Yousra J, et al.
Publicado: (2018)

Correction to: Earlier chronotype in patients with rheumatoid arthritis
por: Habers, G. Esther A., et al.
Publicado: (2021)

How thorough clinical observational studies on rheumatoid arthritis can have an impact on the field
por: van der Helm-van Mil, A. H. M.
Publicado: (2019)

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Is Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti–Citrullinated Protein Antibody–Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward
por: Boer, Aleid C., et al.
Publicado: (2018)

Evaluation of the joint distribution at disease presentation of patients with rheumatoid arthritis: a large study across continents
por: Bergstra, Sytske Anne, et al.
Publicado: (2017)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives
por: Burgers, Leonie E, et al.
Publicado: (2019)

PTPN22 as a rheumatoid arthritis susceptibility but not severity gene
por: Wesoly, J, et al.
Publicado: (2005)

MRI-detected synovitis of the small joints predicts rheumatoid arthritis development in large joint undifferentiated inflammatory arthritis
por: Sidhu, Navkiran, et al.
Publicado: (2021)

Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis
por: Scherer, Hans Ulrich, et al.
Publicado: (2009)

In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis
por: Derksen, Veerle F A M, et al.
Publicado: (2022)

IL2RA is associated with persistence of rheumatoid arthritis
por: van Steenbergen, H.W., et al.
Publicado: (2015)

Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis
por: Rogier, Cleo, et al.
Publicado: (2020)

The invasiveness of fibroblast-like synoviocytes is of relevance for the rate of joint destruction in patients with rheumatoid arthritis and is a patient characteristic
por: Tolboom, TCA, et al.
Publicado: (2005)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

Genetic Variation of the Fc Gamma Receptor 3B Gene and Association with Rheumatoid Arthritis
por: Marques, Rute B., et al.
Publicado: (2010)

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis
por: Reiss, William G., et al.
Publicado: (2015)

The prognostic value of baseline erosions in undifferentiated arthritis
por: Thabet, Mohamed M, et al.
Publicado: (2009)

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation
por: Boeters, Debbie M., et al.
Publicado: (2019)

Morning stiffness precedes the development of rheumatoid arthritis and associates with systemic and subclinical joint inflammation in arthralgia patients
por: Krijbolder, Doortje I, et al.
Publicado: (2021)

The Role of Genetics in Clinically Suspect Arthralgia and Rheumatoid Arthritis Development: A Large Cross‐Sectional Study
por: Maurits, Marc P., et al.
Publicado: (2022)

Is shoulder involvement in clinically suspect arthralgia an early feature of rheumatoid arthritis? A longitudinal ultrasound study
por: Rogier, Cleo, et al.
Publicado: (2020)

TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies
por: van Nies, Jessica AB, et al.
Publicado: (2010)

Increased frequency of intermetatarsal and submetatarsal bursitis in early rheumatoid arthritis: a large case-controlled MRI study
por: Dakkak, Yousra J., et al.
Publicado: (2020)

Sequence of joint tissue inflammation during rheumatoid arthritis development
por: ten Brinck, R. M., et al.
Publicado: (2018)

Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art
por: Boeters, Debbie M, et al.
Publicado: (2017)

A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
por: Ma, M. H. Y., et al.
Publicado: (2020)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pakj17el4vbiavei4nuk5acugt